Clinical Trial Update: Clinical Study of PM1003 in Phase I/IIa Treatment of Advanced Malignant Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Phase I/IIa clinical trial update for PM1003 in advanced solid tumors; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• PM1003

Snippet

Sponsor: Biotheus Inc. | Conditions: Advanced Solid Tumors | Phase 1, Phase 2 | Status: UNKNOWN